Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice

Henry M Smilowitz,1 Lauren J Tarmu,1–3 Mary Melinda Sanders,4 John A Taylor III,5 Dharamainder Choudhary,6 Crystal Xue,7 Nathaniel A Dyment,8 Dan Sasso,1 Xiaomeng Deng,9 James F Hainfeld10 1Department of Cell Biology, University of Connecticut Health Center, Farmington, CT, 2Department of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Smilowitz HM, Tarmu LJ, Sanders MM, Taylor JA III, Choudhary D, Xue C, Dyment NA, Sasso D, Deng X, Hainfeld JF
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) Muscle Invasive Bladder Cancer Gold Nanoparticles Mouse Model Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/6a677bd86f38486ca489f4ed8ba9e204
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6a677bd86f38486ca489f4ed8ba9e204
record_format	dspace
spelling	oai:doaj.org-article:6a677bd86f38486ca489f4ed8ba9e2042021-12-02T02:41:16ZBiodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice1178-2013https://doaj.org/article/6a677bd86f38486ca489f4ed8ba9e2042017-10-01T00:00:00Zhttps://www.dovepress.com/biodistribution-of-gold-nanoparticles-in-bbn-induced-muscle-invasive-b-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Henry M Smilowitz,1 Lauren J Tarmu,1–3 Mary Melinda Sanders,4 John A Taylor III,5 Dharamainder Choudhary,6 Crystal Xue,7 Nathaniel A Dyment,8 Dan Sasso,1 Xiaomeng Deng,9 James F Hainfeld10 1Department of Cell Biology, University of Connecticut Health Center, Farmington, CT, 2Department of Human Behavior, College of Southern Nevada, North Las Vegas, 3Department of Anthropology, University of Nevada, Las Vegas, NV, 4Department of Anatomic Pathology, University of Connecticut Health Center, Farmington, CT, 5Department of Urology, University of Kansas Medical Center, Kansas City, KS, 6Department of Surgery, University of Connecticut Health Center, Farmington, CT, 7George Washington University School of Medicine, Washington, DC, 8Department of Orthopedic Surgery, University of Pennsylvania, Philadelphia, PA, 9David Geffen School of Medicine at UCLA, Los Angeles, CA, 10Nanoprobes, Inc, Yaphank, NY, USA Abstract: Bladder-sparing options are being developed for muscle-invasive bladder cancer in place of radical cystectomy, including the combination of chemotherapy and radiation therapy. We reasoned that improving the radiotherapy component of chemoradiation could improve the control of locally advanced disease. Previously, we showed that gold nanoparticles (AuNPs) are potent enhancers of radiation therapy. We hypothesized that if AuNPs were to preferentially localize to bladder tumors, they may be used to enhance the radiation component of muscle-invasive bladder tumor therapy. Mice were treated with the carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) for 17, 20, and 22 weeks – long enough to induce muscle-invasive tumors. Mice were then anesthetized and injected intravenously with 1.9 nm AuNPs of which most were rapidly cleared from the blood and excreted after a 30–50 minute residence time in the bladder. We found AuNPs distributed throughout the bladder wall, but most of the AuNPs were associated with the stroma surrounding the tumor cells or extracellular keratin produced by the tumor cells. There were relatively few AuNPs in the tumor cells themselves. The AuNPs therefore localized to tumor-associated stroma and this tumor specificity might be useful for specific X-ray dose enhancement therapy of muscle-invasive bladder carcinomas. Keywords: N-butyl-N-(4-hydroxybutyl)nitrosamine, BBN, muscle-invasive bladder cancer, gold nanoparticles, mouse modelSmilowitz HMTarmu LJSanders MMTaylor JA IIIChoudhary DXue CDyment NASasso DDeng XHainfeld JFDove Medical PressarticleN-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)Muscle Invasive Bladder CancerGold NanoparticlesMouse ModelMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 7937-7946 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) Muscle Invasive Bladder Cancer Gold Nanoparticles Mouse Model Medicine (General) R5-920
spellingShingle	N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) Muscle Invasive Bladder Cancer Gold Nanoparticles Mouse Model Medicine (General) R5-920 Smilowitz HM Tarmu LJ Sanders MM Taylor JA III Choudhary D Xue C Dyment NA Sasso D Deng X Hainfeld JF Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice
description	Henry M Smilowitz,1 Lauren J Tarmu,1–3 Mary Melinda Sanders,4 John A Taylor III,5 Dharamainder Choudhary,6 Crystal Xue,7 Nathaniel A Dyment,8 Dan Sasso,1 Xiaomeng Deng,9 James F Hainfeld10 1Department of Cell Biology, University of Connecticut Health Center, Farmington, CT, 2Department of Human Behavior, College of Southern Nevada, North Las Vegas, 3Department of Anthropology, University of Nevada, Las Vegas, NV, 4Department of Anatomic Pathology, University of Connecticut Health Center, Farmington, CT, 5Department of Urology, University of Kansas Medical Center, Kansas City, KS, 6Department of Surgery, University of Connecticut Health Center, Farmington, CT, 7George Washington University School of Medicine, Washington, DC, 8Department of Orthopedic Surgery, University of Pennsylvania, Philadelphia, PA, 9David Geffen School of Medicine at UCLA, Los Angeles, CA, 10Nanoprobes, Inc, Yaphank, NY, USA Abstract: Bladder-sparing options are being developed for muscle-invasive bladder cancer in place of radical cystectomy, including the combination of chemotherapy and radiation therapy. We reasoned that improving the radiotherapy component of chemoradiation could improve the control of locally advanced disease. Previously, we showed that gold nanoparticles (AuNPs) are potent enhancers of radiation therapy. We hypothesized that if AuNPs were to preferentially localize to bladder tumors, they may be used to enhance the radiation component of muscle-invasive bladder tumor therapy. Mice were treated with the carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) for 17, 20, and 22 weeks – long enough to induce muscle-invasive tumors. Mice were then anesthetized and injected intravenously with 1.9 nm AuNPs of which most were rapidly cleared from the blood and excreted after a 30–50 minute residence time in the bladder. We found AuNPs distributed throughout the bladder wall, but most of the AuNPs were associated with the stroma surrounding the tumor cells or extracellular keratin produced by the tumor cells. There were relatively few AuNPs in the tumor cells themselves. The AuNPs therefore localized to tumor-associated stroma and this tumor specificity might be useful for specific X-ray dose enhancement therapy of muscle-invasive bladder carcinomas. Keywords: N-butyl-N-(4-hydroxybutyl)nitrosamine, BBN, muscle-invasive bladder cancer, gold nanoparticles, mouse model
format	article
author	Smilowitz HM Tarmu LJ Sanders MM Taylor JA III Choudhary D Xue C Dyment NA Sasso D Deng X Hainfeld JF
author_facet	Smilowitz HM Tarmu LJ Sanders MM Taylor JA III Choudhary D Xue C Dyment NA Sasso D Deng X Hainfeld JF
author_sort	Smilowitz HM
title	Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice
title_short	Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice
title_full	Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice
title_fullStr	Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice
title_full_unstemmed	Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice
title_sort	biodistribution of gold nanoparticles in bbn-induced muscle-invasive bladder cancer in mice
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/6a677bd86f38486ca489f4ed8ba9e204
work_keys_str_mv	AT smilowitzhm biodistributionofgoldnanoparticlesinbbninducedmuscleinvasivebladdercancerinmice AT tarmulj biodistributionofgoldnanoparticlesinbbninducedmuscleinvasivebladdercancerinmice AT sandersmm biodistributionofgoldnanoparticlesinbbninducedmuscleinvasivebladdercancerinmice AT taylorjaiii biodistributionofgoldnanoparticlesinbbninducedmuscleinvasivebladdercancerinmice AT choudharyd biodistributionofgoldnanoparticlesinbbninducedmuscleinvasivebladdercancerinmice AT xuec biodistributionofgoldnanoparticlesinbbninducedmuscleinvasivebladdercancerinmice AT dymentna biodistributionofgoldnanoparticlesinbbninducedmuscleinvasivebladdercancerinmice AT sassod biodistributionofgoldnanoparticlesinbbninducedmuscleinvasivebladdercancerinmice AT dengx biodistributionofgoldnanoparticlesinbbninducedmuscleinvasivebladdercancerinmice AT hainfeldjf biodistributionofgoldnanoparticlesinbbninducedmuscleinvasivebladdercancerinmice
_version_	1718402292478115840

Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice

Ejemplares similares